Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


miR-Mouse™ Enriched Small RNAs

Product Description
miR-Mouse™ Enriched Small RNAs are purified from pools of up to 10 organs from Balb/c mice. The RNA is also available as a custom product of RNA from strain/gender/age as specified by the researcher. The RNA is extracted using a single-phase reagent containing phenol and guanidinium thiocyanate and the small RNA fraction is enriched by differential precipitation with isopropanol. The large RNA-enriched fraction corresponding to the particular small RNA-enriched preparation is available as a companion product. The small RNA enriched RNA ranges in size from approximately 10 bp to 100 bp and is especially useful for analyzing microRNA and other endogenous small RNAs in particular tissues. The product is supplied at a concentration of 50 ng/uL in a buffer of 0.2 mM EDTA pH 8 in nuclease-free water. For information about custom miR-Mouse™ Enriched Small RNAs from Mouse Tissue contact us at info@biooscientific.com and specify the strain/gender/age you would like to obtain enriched small RNA from.
Product miR-Mouse™ Enriched Small RNAs
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 5156
Quantity 15 ug
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!